595 results on '"Gorin, N.-C."'
Search Results
2. Hématologie et thérapie cellulaire. Historique de l’autogreffe de cellules souches hématopoïétiques : rôle actuel en hématologie. Nouveautés pour le traitement des leucémies aiguës myéloblastiques de l’adulte
3. ALWP registry and achievements
4. Developing Centers Subcommittee: centre experience and results of allo-HSCT
5. Machine learning based predictive modeling for mortality 100 days post allogeneic hematopoietic stem cell transplantation (ALLO-HSCT) in acute leukemia: an EBMT-Acute Leukemia Working Party (ALWP) registry study [Abstract]
6. Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation (HSCT): a survey on behalf of the ALWP of the EBMT [Abstract]
7. Heterogeneity of myeloablative total body irradiation techniques in current clinical practice. A survey of Acute Leukemia Working Party of the EBMT [Abstract]
8. Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT
9. Autologous Stem Cell Transplantation and Cell Therapy for Acute Leukemia
10. Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects
11. A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia
12. Outbreak of Ralstonia pickettii Pseudobacteremia Among Patients With Hematological Malignancies
13. Autologous Bone Marrow Transplantation in Acute Myelocytic Leukemia in Europe: The Role of Marrow Purging
14. Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT
15. Autologous Bone Marrow Transplantation for Acute Leukemia in Remission: An Analysis of 1322 Cases
16. Establishment of an AML-CFU Colony Assay to Evaluate the Sensitivity of Leukemic Progenitors to Cryopreservation: Incidence for Bone Marrow Transplantation
17. A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality
18. Recombinant Human Erythropoietin After Bone Marrow Transplantation — A Placebo Controlled Trial
19. Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients (Bone Marrow Transplantation, (2020), 55, 6, (1114-1125), 10.1038/s41409-020-0803-y)
20. STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma
21. Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation
22. HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia
23. Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents
24. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
25. A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant
26. UNMANIPULATED GRAFT HAPLOINDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION (HAPLO-SCT) IN ACUTE LEUKEMIA: A LONG-TERM FOLLOW-UP SURVEY ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY (ALWP) OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION (EBMT): PH-O130
27. CHEMOTHERAPY DOSE ADJUSTMENT FOR OBESE PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT): A SURVEY ON BEHALF OF THE ALWP OF THE EBMT: PH-O074
28. MACHINE LEARNING BASED PREDICTIVE MODELING FOR MORTALITY 100 DAYS POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) IN ACUTE LEUKEMIA: AN EBMT- ACUTE LEUKEMIA WORKING PARTY (ALWP) REGISTRY STUDY: PH-O072
29. HETEROGENEITY OF MYELOABLATIVE TOTAL BODY IRRADIATION TECHNIQUES IN CURRENT CLINICAL PRACTICE. A SURVEY OF ACUTE LEUKEMIA WORKING PARTY OF THE EBMT: PH-O060
30. Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantation
31. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow
32. Haplo donors for all: are we there: 103
33. Human AML cells in NOD/SCID mice: engraftment potential and gene expression
34. Interest of the association azacitidine–lenalidomide as frontline therapy in high-risk myelodysplasia or acute myeloid leukemia with complex karyotype
35. Stem cells therapy in radiation injuries from bench to bedside: P1061
36. Stem cell therapy to counteract the loss of regenerative capacity of colon after treatment of colorectal cancer: pre-clinical study: P997
37. Impact of the presence of an internal tandem duplicate of FIT3 receptor on the outcome of adult patients with acute myelocytic leukaemia autografted in first remsision (CR1): P924
38. Acute Leukaemia Working Party Alternative Donors Subcommittee: ongoing activities: 201
39. Developing Centers Subcommittee: centre experience and results of allo-HSCT: 202
40. Treatment of relapse after allogeneic stem cell transplantation In acute leukaemia: 200
41. Bortezomib (Velcade)-thalidomide-dexamethasone is superior to thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: 0117
42. Essai clinique évaluant l’efficacité des injections de cellules stromales mésenchymateuses pour le traitement des complications pelviennes chroniques induites par la radiothérapie
43. Cell culture bags allow a large extent of ex vivo expansion of LTC-IC and functional mature cells which can subsequently be frozen: interest for large-scale clinical applications
44. Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques
45. Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission: Results and prognostic factors in 326 consecutive patients
46. A prospective study on the feasibility of related and unrelated donor search and haematopoietic cell transplantation for adults with acute leukaemia at 31 European transplant centres: 187
47. Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation
48. Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation
49. Post remission consolidation by autologous HCT for AML in CR1, negative implications for subsequent allogeneic HCT in CR2. A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
50. The ex vivo expansion capacity of normal human bone marrow cellsis dependent on experimental conditions: role of the cell concentration, serum and CD34+ cell selection in stroma-free cultures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.